The impact of Sirolimus Eluting stents in interventional cardiology
- 30 June 2004
- journal article
- editorial
- Published by Elsevier in International Journal of Cardiology
- Vol. 95 (2-3) , 117-121
- https://doi.org/10.1016/j.ijcard.2003.10.010
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- The impact of sirolimus-eluting stents in diabetics: Results from the SIRIUS trialJournal of the American College of Cardiology, 2003
- One-year follow-up of the SIRIUS study: A randomized study with the sirolimus-eluting Bx VELOCITY in the treatment of patients with denovo native coronary artery lesionsJournal of the American College of Cardiology, 2003
- Two-year follow-up of the RAVEL study: A randomized study with the sirolimus-eluting Bx VELOCITY stent in the treatment of patients with denovo native coronary artery lesionsJournal of the American College of Cardiology, 2003
- Two-Year Angiographic and Intravascular Ultrasound Follow-Up After Implantation of Sirolimus-Eluting Stents in Human Coronary ArteriesCirculation, 2003
- Mechanism of Late In-Stent Restenosis After Implantation of a Paclitaxel Derivate–Eluting Polymer Stent System in HumansCirculation, 2002
- 7-Hexanoyltaxol–Eluting Stent for Prevention of Neointimal GrowthCirculation, 2002
- Sirolimus-eluting stents: a review of experimental and clinical findings.Clinical Research in Cardiology, 2002
- Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary InterventionA Randomized Controlled TrialJAMA, 2002
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- First Clinical Experience With a Paclitaxel Derivate–Eluting Polymer Stent System Implantation for In-Stent RestenosisCirculation, 2002